viewB&M European Value Retail SA

B&M European Value Retail raises profit forecast again as lockdown surge continues

UK stores saw like-for-like sales grow by 19% in the second quarter

B&M European Value Retail SA -

B&M European Value Retail (LON:BME)  has raised its profit forecast and said sales had continued to grow strongly in recent months with customers also spending more.

The basic homewares retailer has been a clear winner from the changing shopping patterns during lockdown restrictions and revenues rose by 25.3% in the six months to 26 September with 23% like-for-like improvement.

UK stores saw like-for-like sales grow by 19% in the second quarter with revenues continuing to increase at the rate into the second half.

As a result, underlying profits for the half-year are now forecast at £285mln against a previous estimate of £250-270mln.

B&M has also accelerated its store opening programme with 40-45 new UK stores to open this year, most of which will be in the fourth quarter.

Babou in France (since reopening) and convenience chain Heron Foods have also both seen sales grow on a like-for-like basis, said the FTSE100 group.

Simon Arora, chief executive, noted: "Our group has performed well in the first half. Our business model is proving well-attuned to the evolving needs of customers, given our combination of everyday value across a broad range of product categories being sold at convenient out-of-town locations.”

Quick facts: B&M European Value Retail SA

Price: 488.1 GBX

Market: LSE
Market Cap: £4.88 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


SourceBio International gets set for IPO as Covid-19 testing demand becomes...

SourceBio International's Jay LeCoque talks to Proactive London's Katie Pilbeam ahead of their IPO on AIM. He explains that Covid-19 is now their main focus, to support the government effort to get the pandemic testing campaign under control. The IPO, values the company at £120m, which Jay...

9 hours, 43 minutes ago

2 min read